FSAGX
Price
$41.95
Change
+$0.42 (+1.01%)
Updated
Aug 7 closing price
Net Assets
2.33B
SGDIX
Price
$83.09
Change
+$1.57 (+1.93%)
Updated
Aug 7 closing price
Net Assets
1.25B
Interact to see
Advertisement

FSAGX vs SGDIX

Header iconFSAGX vs SGDIX Comparison
Open Charts FSAGX vs SGDIXBanner chart's image
Fidelity Select Gold
Price$41.95
Change+$0.42 (+1.01%)
VolumeN/A
Net Assets2.33B
Sprott Gold Equity Institutional
Price$83.09
Change+$1.57 (+1.93%)
VolumeN/A
Net Assets1.25B
FSAGX vs SGDIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSAGX vs. SGDIX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSAGX is a Buy and SGDIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSAGX has more cash in the bank: 2.33B vs. SGDIX (1.25B). FSAGX pays higher dividends than SGDIX: FSAGX (2.25) vs SGDIX (0.00). FSAGX was incepted earlier than SGDIX: FSAGX (40 years) vs SGDIX (6 years). SGDIX (1.17) is less costly to investors than FSAGX (0.68). SGDIX is a more actively managed with annual turnover of: 26.00 vs. FSAGX (17.00). FSAGX has a lower initial minimum investment than SGDIX: FSAGX (0) vs SGDIX (1000000). FSAGX (75.67) and SGDIX (72.06) have marching annual gain over last year. SGDIX return over 5 years is better than : 37.84 vs. FSAGX (30.89).
FSAGXSGDIXFSAGX / SGDIX
Total Expense Ratio0.681.1758%
Annual Report Gross Expense Ratio0.681.1758%
Fund Existence40 years6 years-
Gain YTD68.95856.378122%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.33B1.25B186%
Annual Yield % from dividends2.250.00-
Returns for 1 year75.6772.06105%
Returns for 3 years106.8197.82109%
Returns for 5 years30.8937.8482%
Returns for 10 years235.371765.5913%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYTOF0.100.01
+13.01%
Altamira Therapeutics Ltd.
COCSF8.520.29
+3.56%
Coca-Cola FEMSA S.A.B de CV
LUMB14.00N/A
N/A
Lumbee Guaranty Bank
OJIPY51.78N/A
N/A
Oji Holdings Corp
JVCZY46.62N/A
N/A
JVCKenwood Corp.